Tau, ADNP, and sex

Illana Gozes

doi:10.1002/cm.21776

Tau, ADNP, and sex

Illana Gozes^*

^*Corresponding author for this work

Human Molecular Genetics Biochemistry

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

With 50 years to the original discovery of Tau, I gave here my perspective, looking through the prism of activity-dependent neuroprotective protein (ADNP), and the influence of sex. My starting point was vasoactive intestinal peptide (VIP), a regulator of ADNP. I then moved to the original discovery of ADNP and its active neuroprotective site, NAP, drug candidate, davunetide. Tau–ADNP–NAP interactions were then explained with emphasis on sex and future translational medicine.

Original language	English
Pages (from-to)	16-23
Number of pages	8
Journal	Cytoskeleton
Volume	81
Issue number	1
DOIs	https://doi.org/10.1002/cm.21776
State	Published - Jan 2024

Funding

Funders	Funder number
Anne and Alex Cohen
Elton Laboratory for Molecular Neuroendocrinology
Tel Aviv University

Keywords

ADNP
NAP (davunetide)
Tau
sex

Access to Document

10.1002/cm.21776

Cite this

@article{4445acf3d4d944ce8137a6cbd2664326,

title = "Tau, ADNP, and sex",

abstract = "With 50 years to the original discovery of Tau, I gave here my perspective, looking through the prism of activity-dependent neuroprotective protein (ADNP), and the influence of sex. My starting point was vasoactive intestinal peptide (VIP), a regulator of ADNP. I then moved to the original discovery of ADNP and its active neuroprotective site, NAP, drug candidate, davunetide. Tau–ADNP–NAP interactions were then explained with emphasis on sex and future translational medicine.",

keywords = "ADNP, NAP (davunetide), Tau, sex",

author = "Illana Gozes",

note = "Publisher Copyright: {\textcopyright} 2023 The Author. Cytoskeleton published by Wiley Periodicals LLC.",

year = "2024",

month = jan,

doi = "10.1002/cm.21776",

language = "אנגלית",

volume = "81",

pages = "16--23",

journal = "Cytoskeleton",

issn = "1949-3584",

publisher = "Wiley-Liss Inc.",

number = "1",

}

TY - JOUR

T1 - Tau, ADNP, and sex

AU - Gozes, Illana

PY - 2024/1

Y1 - 2024/1

N2 - With 50 years to the original discovery of Tau, I gave here my perspective, looking through the prism of activity-dependent neuroprotective protein (ADNP), and the influence of sex. My starting point was vasoactive intestinal peptide (VIP), a regulator of ADNP. I then moved to the original discovery of ADNP and its active neuroprotective site, NAP, drug candidate, davunetide. Tau–ADNP–NAP interactions were then explained with emphasis on sex and future translational medicine.

AB - With 50 years to the original discovery of Tau, I gave here my perspective, looking through the prism of activity-dependent neuroprotective protein (ADNP), and the influence of sex. My starting point was vasoactive intestinal peptide (VIP), a regulator of ADNP. I then moved to the original discovery of ADNP and its active neuroprotective site, NAP, drug candidate, davunetide. Tau–ADNP–NAP interactions were then explained with emphasis on sex and future translational medicine.

KW - ADNP

KW - NAP (davunetide)

KW - Tau

KW - sex

UR - http://www.scopus.com/inward/record.url?scp=85167735281&partnerID=8YFLogxK

U2 - 10.1002/cm.21776

DO - 10.1002/cm.21776

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 37572043

AN - SCOPUS:85167735281

SN - 1949-3584

VL - 81

SP - 16

EP - 23

JO - Cytoskeleton

JF - Cytoskeleton

IS - 1

ER -

Tau, ADNP, and sex

Abstract

Funding

Keywords

Access to Document

Other files and links

Fingerprint

Cite this